Cargando…

Effect of a Histone Deacetylases Inhibitor of IL-18 and TNF-Alpha Secretion in Vitro

BACKGROUND: Interleukin-18 (IL-18) and Tumor Necrosis Factor-alpha (TNF-α) are proinflammatory cytokines that increased the development of Th1 immune response, but have a different type of regulation of the gene expression. Whereas TNF-α has an inducible expression, IL-18 is translated as an inactiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dobreva, Zlatka Georgieva, Grigorov, Boncho Grigorov, Stanilova, Spaska Angelova
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Republic of Macedonia 2018
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839430/ https://www.ncbi.nlm.nih.gov/pubmed/29531586 http://dx.doi.org/10.3889/oamjms.2018.075

Ejemplares similares

Effect of a Small Selective Inhibitor of C-Jun N-Terminal Kinase on the Inducible mRNA Expression of Interleukin-6 and Interleukin-18
por: Stanilova, Spaska A., et al.
Publicado: (2019)

The influence of JNK and P38 MAPK inhibition on IL-12P40 and IL-23 production depending on IL12B promoter polymorphism
por: Dobreva, Zlatka Georgieva, et al.
Publicado: (2009)

Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha
por: Stanilov, Noyko, et al.
Publicado: (2014)

Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer
por: Velikova, Tsvetelina Veselinova, et al.
Publicado: (2020)

Functional relevance of IL-10 promoter polymorphisms for sepsis development
por: Stanilova, Spaska A
Publicado: (2010)

New ELISA Kits using C3 Binding Glycoprotein from Cuscuta europea Detect Mainly IgM CIC in Rheumatoid Arthritis and Progressive Systemic Sclerosis, but not in Systemic Lupus Erythematosus
por: Stanilova, Spaska Angelova, et al.
Publicado: (2003)

The role of IL-18 in addition to Th17 cytokines in rheumatoid arthritis development and treatment in women
por: Vasilev, Georgi, et al.
Publicado: (2021)

Genetic variation of TGF-ΒR2 as a protective genotype for the development of colorectal cancer in men
por: Stanilov, Noyko, et al.
Publicado: (2021)

Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
por: Grabiec, Aleksander M, et al.
Publicado: (2011)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer
por: Amnekar, Ramchandra Vigay, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors: A Novel Strategy for Neuroprotection and Cardioprotection Following Ischemia/Reperfusion Injury
por: Pickell, Zachary, et al.
Publicado: (2020)

Association of single nucleotide polymorphism at position −308 of the tumor necrosis factor-alpha gene with ankylosing spondylitis and rheumatoid arthritis
por: Manolova, Irena, et al.
Publicado: (2014)

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma
por: Pratap, Uday P, et al.
Publicado: (2021)

A COMPARATIVE ANALYSIS TO DETERMINE THE OPTIMUM HISTONE DEACETYLASE INHIBITORS AND ADMINISTRATION ROUTE FOR IMPROVING SURVIVAL AND ORGAN INJURY IN RATS AFTER HEMORRHAGIC SHOCK
por: Niu, Kunwei, et al.
Publicado: (2023)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Influence of IL10 and TGFB1 Promoter Polymorphisms on Serum Cytokine Levels in Development and Severity of RA
por: Vasilev, Georgi, et al.
Publicado: (2022)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Carboxylic acid derivatives of histone deacetylase inhibitors induce full length SMN2 transcripts: a promising target for spinal muscular atrophy therapeutics
por: Dayangac-Erden, Didem, et al.
Publicado: (2011)

Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples
por: Berendsen, Sharon, et al.
Publicado: (2019)

Histone deacetylase inhibitors in multiple myeloma
por: Deleu, Sarah, et al.
Publicado: (2009)

Histone deacetylase inhibitors in Hodgkin lymphoma
por: Buglio, Daniela, et al.
Publicado: (2010)

Clinical Toxicities of Histone Deacetylase Inhibitors
por: Subramanian, Srividya, et al.
Publicado: (2010)

Acetylation and Histone Deacetylase Inhibitors in Cancer
por: Kortenhorst, Madeleine S. Q., et al.
Publicado: (2006)

Histone Deacetylase Inhibitors as Anticancer Drugs
por: Eckschlager, Tomas, et al.
Publicado: (2017)

The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)

Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
por: Hassell, Kelly N.
Publicado: (2019)

Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
por: Singh, Suman, et al.
Publicado: (2012)

Hypotheses and facts for genetic factors related to severe COVID-19
por: Kotsev, Stanislav Vasilev, et al.
Publicado: (2021)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Healthcare in Africa
por: Grigorov, V
Publicado: (2009)

Invasive and anticoagulant treatment for coronary ectasia: a single operator’s experience in a tertiary hospital in South Africa
por: Grigorov, V
Publicado: (2009)

Effects of Pentoxifylline on TNF-Alpha and Lung Histopathology in HCl-Induced Lung Injury
por: de Oliveira-Júnior, Itamar Souza, et al.
Publicado: (2008)

Histone deacetylase inhibition enhances the therapeutic effects of methotrexate on primary central nervous system lymphoma
por: Fujimoto, Kenji, et al.
Publicado: (2020)

Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin
por: Saraiva, Raúl G., et al.
Publicado: (2018)

Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)

IL-10 and class 1 histone deacetylases act synergistically and independently on the secretion of proinflammatory mediators in alveolar macrophages
por: Stanfield, Brent A., et al.
Publicado: (2021)

Histone deacetylase inhibitors as novel anticancer therapeutics
por: Walkinshaw, D.R., et al.
Publicado: (2008)

Regulation of Immune Responses by Histone Deacetylase Inhibitors
por: Licciardi, Paul V., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cgmoes17s0qvqpa22lvjabs6le